173 related articles for article (PubMed ID: 22382878)
21. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
22. The V(H)1-69-expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21(low) phenotype.
Visentini M; Cagliuso M; Conti V; Carbonari M; Casato M; Fiorilli M
Blood; 2011 Sep; 118(12):3440-1; author reply 3442. PubMed ID: 21940829
[No Abstract] [Full Text] [Related]
23. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Polzien F; Schott P; Mihm S; Ramadori G; Hartmann H
J Hepatol; 1997 Jul; 27(1):63-71. PubMed ID: 9252075
[TBL] [Abstract][Full Text] [Related]
24. In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia.
Schott P; Polzien F; Müller-Issberner A; Ramadori G; Hartmann H
J Hepatol; 1998 Jan; 28(1):17-26. PubMed ID: 9537859
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
[TBL] [Abstract][Full Text] [Related]
26. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia.
Monteverde A; Ballarè M; Pileri S
Springer Semin Immunopathol; 1997; 19(1):99-110. PubMed ID: 9266634
[TBL] [Abstract][Full Text] [Related]
27. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia.
Agnello V; Zhang QX; Abel G; Knight GB
Clin Exp Rheumatol; 1995; 13 Suppl 13():S101-4. PubMed ID: 8730487
[TBL] [Abstract][Full Text] [Related]
28. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
29. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis.
Holz LE; Yoon JC; Raghuraman S; Moir S; Sneller MC; Rehermann B
Hepatology; 2012 Nov; 56(5):1602-10. PubMed ID: 22556016
[TBL] [Abstract][Full Text] [Related]
30. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
31. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.
Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P
Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883
[TBL] [Abstract][Full Text] [Related]
32. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection.
Buezo GF; García-Buey M; Rios-Buceta L; Borque MJ; Aragües M; Daudén E
Int J Dermatol; 1996 Feb; 35(2):112-5. PubMed ID: 8850039
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus (HCV) RNA and human immunodeficiency virus (HIV) p24 antigen in the cryoglobulin of hemophiliacs with HIV and/or HCV infection.
Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Gotoh M
Clin Infect Dis; 1994 May; 18(5):832-3. PubMed ID: 8075285
[No Abstract] [Full Text] [Related]
34. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection and clonal B-cell expansion.
Sansonno D; Cornacchiulo V; Iacobelli AR; Gatti P; Distasi M; Dammacco F
Clin Exp Rheumatol; 1996; 14 Suppl 14():S45-50. PubMed ID: 8722199
[TBL] [Abstract][Full Text] [Related]
36. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
37. Cerebral ischemic attack secondary to hepatitis C virus infection.
Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
[TBL] [Abstract][Full Text] [Related]
38. Cryoglobulins: putative effectors of adaptive immune response.
Basile U; Napodano C; Marino M; Gulli F; Colantuono S; Casato M; Pocino K; Basile V; Todi L; Rapaccini GL; Visentini M
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):171-179. PubMed ID: 33124568
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 Jan; 154(1):413-21. PubMed ID: 7527818
[TBL] [Abstract][Full Text] [Related]
40. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia.
Sansonno D; De Vita S; Iacobelli AR; Cornacchiulo V; Boiocchi M; Dammacco F
J Immunol; 1998 Apr; 160(7):3594-601. PubMed ID: 9531323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
